Covestor LTD Arbutus Biopharma Corp Transaction History
Covestor LTD
- $155 Million
- Q2 2024
A detailed history of Covestor LTD transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Covestor LTD holds 6,700 shares of ABUS stock, worth $25,728. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,700
Previous 67
9900.0%
Holding current value
$25,728
Previous $0
Infinity%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
138Shares Held
95.5MCall Options Held
3.44MPut Options Held
377K-
Morgan Stanley New York, NY21MShares$80.5 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$49.4 Million30.08% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$44.4 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.57MShares$32.9 Million10.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.02MShares$27 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $576M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...